EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry

Charles Gaulin, Georgina Osorio

Journal of Scientific Innovation in Medicine · 2019

DOI: 10.29024/jsim.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Scientific Innovation in Medicine, 2019. Verfasst von Charles Gaulin und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gaulin, C., & Osorio, G. (2019). Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry. Journal of Scientific Innovation in Medicine. https://doi.org/10.29024/jsim.11

Vancouver

Gaulin C, Osorio G. Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry. Journal of Scientific Innovation in Medicine. 2019. doi:10.29024/jsim.11

BibTeX
@article{Gaulin2019,
  author = {Gaulin, Charles and Osorio, Georgina},
  title = {Patient Reported Outcomes in Metastatic Breast Cancer Studies: Evaluating the Impact of the FDA Guidance for Industry},
  journal = {Journal of Scientific Innovation in Medicine},
  year = {2019},
  doi = {10.29024/jsim.11}
}
Kostenlos starten →